Sensitization effect
- PMID: 3154413
Sensitization effect
Abstract
1. Approximately 15% of males were sensitized by transfusions before their first grafts. About 40% of females were sensitized by pregnancies and transfusions. Following graft rejection about 60% of males and females were sensitized. 2. The one-year graft survival of nonsensitized and sensitized patients differed by 4 to 7% in first, second, and third transplants. The difference developed very early and even on the first day after transplantation. 3. Patients with a high peak level of antibody tended to have lower graft survival, particularly in regrafted patients. If the peak level of antibody was under 50% panel reactive antibody, graft survival was the same as in patients who never had preformed cytotoxins. 4. Parous women without transfusions and no preformed antibodies had a 49% one-year graft survival with no transfusions and 71% with transfusions. Similar findings were noted in regrafted parous women and those with preformed antibodies. Thus, pregnancy exerted a deleterious effect which was reversed by transfusions. 5. Between the best and worst HLA-A,B,DR match there was a 19% difference in one-year graft survival for nonsensitized patients, and a 26% difference in patients sensitized to more than 50% of the panel. A similar difference was noted in regrafted patients for sensitized and highly sensitized patients. 6. Transfusions had a greater effect on the outcome of transplantation than the state of sensitization. First cadaver donor patients without transfusions and without antibodies had a one-year graft survival of 57% whereas patients with more than 50% panel reactive antibodies had graft survival of 59 to 71%.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Sensitization in renal transplantation.Clin Transpl. 1991:313-23. Clin Transpl. 1991. PMID: 1820127
-
Sensitization and crossmatching in renal transplantation.Clin Transpl. 1989:379-90. Clin Transpl. 1989. PMID: 2487606
-
The transfusion effect.Clin Transpl. 1986:175-88. Clin Transpl. 1986. PMID: 3154399
-
Clinical transplants 1988. Overview.Clin Transpl. 1988:409-34. Clin Transpl. 1988. PMID: 3154492 Review.
-
HLA compatibility and organ transplant survival. Collaborative Transplant Study.Rev Immunogenet. 1999;1(3):334-42. Rev Immunogenet. 1999. PMID: 11256424 Review.
Cited by
-
Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group.J Korean Surg Soc. 2012 Jun;82(6):335-9. doi: 10.4174/jkss.2012.82.6.335. Epub 2012 May 29. J Korean Surg Soc. 2012. PMID: 22708094 Free PMC article.
-
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.Nat Rev Nephrol. 2018 Mar;14(3):151-164. doi: 10.1038/nrneph.2017.181. Epub 2018 Jan 22. Nat Rev Nephrol. 2018. PMID: 29355169 Review.
-
Cardiac transplantation. Selection, immunosuppression, and survival.West J Med. 1988 Nov;149(5):572-82. West J Med. 1988. PMID: 3074557 Free PMC article. Review.
-
Sex-Specific Differences in HLA Antibodies after Pneumococcal Vaccination in Kidney Transplant Recipients.Vaccines (Basel). 2019 Aug 6;7(3):84. doi: 10.3390/vaccines7030084. Vaccines (Basel). 2019. PMID: 31390822 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials